196440 | Batimastat - CAS 130370-60-4 - Calbiochem

196440
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitéeDisponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Voir les Prix & la Disponibilité
      Click To Print This Page

      Aperçu

      Replacement Information

      Tableau de caractéristiques principal

      Empirical FormulaCAS #
      C₂₃H₃₁N₃O₄S₂ 130370-60-4

      Prix & Disponibilité

      RéférenceDisponibilité Conditionnement Qté Prix Quantité
      196440-5MG
      Récupération des données relatives à la disponibilité...
      Disponibilité limitéeDisponibilité limitée
      En stock 
      Interrompu(e)
      Disponible en quantités limitées
      Disponibilité à confirmer
        Pour le restant : Nous vous tiendrons informé
          Pour le restant : Nous vous tiendrons informé
          Nous vous tiendrons informé
          Contacter le Service Clients

          Flacon en verre 5 mg
          Prix en cours de récupération
          Le prix n'a pas pu être récupéré
          La quantité minimale doit être un multiple de
          À la validation de la commande Plus d'informations
          Vous avez sauvegardé ()
           
          Demander le prix
          Description
          OverviewA Marimastat (Cat. No. 444289) type of peptidyl hydroxamate-based inhibitor that potently inhibits a broad-spectrum of metalloproteinases, including MMP-1, MMP-2, MMP-3/stromelysin, MMP-7/matrilysin, MMP-9, ΔMT1 (MMP-14 without TM domain), ADAM8, and ADAM17/TACE (IC50 = 3, 4, 20, 6, 4, 2.08, 51.3, and 19 nM, respectively), by targeting both the substrate binding site and the active-site Zn2+, while being much less potent toward ACE (Angiotensin Converting Enzyme) or α-secretase (IC50 = 1.6 and 3.3 µM, respectively). Batimastat is widely used in studying the involvement of MMPs in cancinogenesis and non-cancer pathological processes both in cultures in vitro and in animals in vivo. Also available as a 25 mM solution in DMSO (Cat. No. 508408).
          Catalogue Number196440
          Brand Family Calbiochem®
          Synonyms(4-N-Hydroxyamino)-2R-isobutyl-3S-(thienylthiomethyl)succinyl)-L-phenylalanine-N-methylamide, BB-94
          References
          ReferencesSchlomann, U., et al. 2002. J. Biol. Chem. 277, 48210.
          Whittaker, M., et al. 1999. Chem. Rev. 99, 2735.
          Parvathy, S., et al. 1998. Biochemistry 37, 1680.
          Parvathy, S., et al. 1998. FEBS Lett. 431, 63.
          Yamamoto, M., et al. 1998. J. Med. Chem. 41, 1209.
          Moss, M.L., et al. 1997. Nature 385, 733.
          Eccles, S.A., et al. 1996. Cancer Res. 56, 2815.
          Brown, P.D. 1995. Advan. Enzyme Regul. 35, 293.
          Wang, X., et al. 1994. Cancer Res. 54, 4726.
          Davies, B., et al. 1993. Cancer Res. 53, 2087.
          Product Information
          CAS number130370-60-4
          FormOff-white solid
          Hill FormulaC₂₃H₃₁N₃O₄S₂
          Chemical formulaC₂₃H₃₁N₃O₄S₂
          Structure formula ImageStructure formula Image
          Applications
          ApplicationBatimastat, CAS 130370-60-4, is a potent inhibitor of a several metalloproteinases, including MMP-1, 2, 3, 7, 9, ΔMT1, ADAM8 & ADAM17/TACE (IC50 = 3, 4, 20, 6, 4, 2.08, 51.3 & 19 nM, respectively).
          Biological Information
          Purity≥98% by HPLC
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          FDS

          Titre

          Fiche de données de sécurité des matériaux (FDS) 

          Certificats d'analyse

          TitreNuméro de lot
          196440

          Références bibliographiques

          Aperçu de la référence bibliographique
          Schlomann, U., et al. 2002. J. Biol. Chem. 277, 48210.
          Whittaker, M., et al. 1999. Chem. Rev. 99, 2735.
          Parvathy, S., et al. 1998. Biochemistry 37, 1680.
          Parvathy, S., et al. 1998. FEBS Lett. 431, 63.
          Yamamoto, M., et al. 1998. J. Med. Chem. 41, 1209.
          Moss, M.L., et al. 1997. Nature 385, 733.
          Eccles, S.A., et al. 1996. Cancer Res. 56, 2815.
          Brown, P.D. 1995. Advan. Enzyme Regul. 35, 293.
          Wang, X., et al. 1994. Cancer Res. 54, 4726.
          Davies, B., et al. 1993. Cancer Res. 53, 2087.
          Fiche technique

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision12-August-2010 RFH
          Synonyms(4-N-Hydroxyamino)-2R-isobutyl-3S-(thienylthiomethyl)succinyl)-L-phenylalanine-N-methylamide, BB-94
          DescriptionA Marimastat (Cat. No. 444289) type of peptidyl hydroxamate-based inhibitor that potently inhibits a broad-spectrum of metalloproteinases, including MMP-1, MMP-2, MMP-3/stromelysin, MMP-7/matrilysin, MMP-9, ΔMT1 (MMP-14 without TM domain), ADAM8, and ADAM17/TACE (IC50 = 3, 4, 20, 6, 4, 2.08, 51.3, and 19 nM, respectively), by targeting both the substrate binding site and the active-site Zn2+, while being much less potent toward ACE (Angiotensin Converting Enzyme) or α-secretase (IC50 = 1.6 and 3.3 µM, respectively). Batimastat is widely used in studying the involvement of MMPs in cancinogenesis and non-cancer pathological processes both in cultures in vitro and in animals in vivo.
          FormOff-white solid
          Intert gas (Yes/No) Packaged under inert gas
          CAS number130370-60-4
          Chemical formulaC₂₃H₃₁N₃O₄S₂
          Structure formulaStructure formula
          Purity≥98% by HPLC
          SolubilityDMSO (50 mg/ml)
          Storage +2°C to +8°C
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
          Toxicity Standard Handling
          ReferencesSchlomann, U., et al. 2002. J. Biol. Chem. 277, 48210.
          Whittaker, M., et al. 1999. Chem. Rev. 99, 2735.
          Parvathy, S., et al. 1998. Biochemistry 37, 1680.
          Parvathy, S., et al. 1998. FEBS Lett. 431, 63.
          Yamamoto, M., et al. 1998. J. Med. Chem. 41, 1209.
          Moss, M.L., et al. 1997. Nature 385, 733.
          Eccles, S.A., et al. 1996. Cancer Res. 56, 2815.
          Brown, P.D. 1995. Advan. Enzyme Regul. 35, 293.
          Wang, X., et al. 1994. Cancer Res. 54, 4726.
          Davies, B., et al. 1993. Cancer Res. 53, 2087.